These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29643301)

  • 21. Online coupling of analytical hydrophobic interaction chromatography with native mass spectrometry for the characterization of monoclonal antibodies and related products.
    Yan Y; Xing T; Wang S; Daly TJ; Li N
    J Pharm Biomed Anal; 2020 Jul; 186():113313. PubMed ID: 32371326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selecting an optimal antibody for antibody-drug conjugate therapy: internalization and intracellular localization.
    Harper J; Mao S; Strout P; Kamal A
    Methods Mol Biol; 2013; 1045():41-9. PubMed ID: 23913140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of ADCs by Native Mass Spectrometry.
    Hernandez-Alba O; Ehkirch A; Beck A; Cianférani S
    Methods Mol Biol; 2020; 2078():197-211. PubMed ID: 31643058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Approaches to Interchain Cysteine-Linked ADC Characterization by Mass Spectrometry.
    Valliere-Douglass JF; Hengel SM; Pan LY
    Mol Pharm; 2015 Jun; 12(6):1774-83. PubMed ID: 25474122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The Characterization of Drug-to-Antibody Ratio and Isoforms of ADCs Using LC and MS Technologies].
    Iizuka R; Kotch F; Xu A; Porter T; Shion H; Birdsall R; Chen W
    Yakugaku Zasshi; 2017; 137(5):525-528. PubMed ID: 28458283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioanalytical assay strategies for the development of antibody-drug conjugate biotherapeutics.
    Kaur S; Xu K; Saad OM; Dere RC; Carrasco-Triguero M
    Bioanalysis; 2013 Jan; 5(2):201-26. PubMed ID: 23330562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Innovative native MS methodologies for antibody drug conjugate characterization: High resolution native MS and IM-MS for average DAR and DAR distribution assessment.
    Debaene F; Boeuf A; Wagner-Rousset E; Colas O; Ayoub D; Corvaïa N; Van Dorsselaer A; Beck A; Cianférani S
    Anal Chem; 2014 Nov; 86(21):10674-83. PubMed ID: 25270580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current Analytical Strategies for Antibody-Drug Conjugates in Biomatrices.
    Qin Q; Gong L
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformation and dynamics of interchain cysteine-linked antibody-drug conjugates as revealed by hydrogen/deuterium exchange mass spectrometry.
    Pan LY; Salas-Solano O; Valliere-Douglass JF
    Anal Chem; 2014 Mar; 86(5):2657-64. PubMed ID: 24512515
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioanalytical Assays for Pharmacokinetic and Biodistribution Study of Antibody-Drug Conjugates.
    Yin L; Xu A; Zhao Y; Gu J
    Drug Metab Dispos; 2023 Oct; 51(10):1324-1331. PubMed ID: 37290939
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies.
    Ducry L; Stump B
    Bioconjug Chem; 2010 Jan; 21(1):5-13. PubMed ID: 19769391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insights into antibody-drug conjugates: bioanalysis and biomeasures in discovery.
    Clark T; Han X; King L; Barletta F
    Bioanalysis; 2013 May; 5(9):985-7. PubMed ID: 23641689
    [No Abstract]   [Full Text] [Related]  

  • 33. An enzymatic deconjugation method for the analysis of small molecule active drugs on antibody-drug conjugates.
    Li Y; Gu C; Gruenhagen J; Yehl P; Chetwyn NP; Medley CD
    MAbs; 2016; 8(4):698-705. PubMed ID: 26891281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PK assays for antibody-drug conjugates: case study with ado-trastuzumab emtansine.
    Dere R; Yi JH; Lei C; Saad OM; Huang C; Li Y; Baudys J; Kaur S
    Bioanalysis; 2013 May; 5(9):1025-40. PubMed ID: 23641694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Magnetic Beads for Desalting of Monoclonal Antibodies and Antibody-Drug Conjugates.
    Källsten M; Ghorasaini M; Hartmann R; Lehmann F; Bergquist J; Kovac L; Lind SB
    Anal Chem; 2020 Jul; 92(13):9001-9007. PubMed ID: 32441508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Physical Stability Studies of Antibody-Drug Conjugates (ADCs) Under Stressed Conditions.
    Adem YT
    Methods Mol Biol; 2020; 2078():301-311. PubMed ID: 31643066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LC/MS/MS Bioanalysis of Protein-Drug Conjugates-The Importance of Incorporating Succinimide Hydrolysis Products.
    Shi C; Goldberg S; Lin T; Dudkin V; Widdison W; Harris L; Wilhelm S; Jmeian Y; Davis D; O'Neil K; Weng N; Jian W
    Anal Chem; 2018 Apr; 90(8):5314-5321. PubMed ID: 29589741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibody-drug conjugate bioanalysis using LB-LC-MS/MS hybrid assays: strategies, methodology and correlation to ligand-binding assays.
    Wang J; Gu H; Liu A; Kozhich A; Rangan V; Myler H; Luo L; Wong R; Sun H; Wang B; Vezina HE; Deshpande S; Zhang Y; Yang Z; Olah TV; Aubry AF; Arnold ME; Pillutla R; DeSilva B
    Bioanalysis; 2016 Jul; 8(13):1383-401. PubMed ID: 27277879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-Resolution Capillary Zone Electrophoresis with Mass Spectrometry Peptide Mapping of Therapeutic Proteins: Peptide Recovery and Post-translational Modification Analysis in Monoclonal Antibodies and Antibody-Drug Conjugates.
    Dada OO; Zhao Y; Jaya N; Salas-Solano O
    Anal Chem; 2017 Nov; 89(21):11236-11242. PubMed ID: 28984442
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current possibilities of liquid chromatography for the characterization of antibody-drug conjugates.
    Bobály B; Fleury-Souverain S; Beck A; Veuthey JL; Guillarme D; Fekete S
    J Pharm Biomed Anal; 2018 Jan; 147():493-505. PubMed ID: 28688616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.